NCT00068380View on ClinicalTrials.gov

A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Recurrent Gastric CancerStage IV Gastric Cancer
Interventions
DRUG

imatinib mesylate

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00068380 - A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer | Biotech Hunter | Biotech Hunter